VISUfarma are launching VISUfly sachets: a dietary supplement with a unique blend of natural enzymes, antioxidants, and collagen whose key ingredients help provide support for those with vitreous floaters (myodesopsia)
Mar 27, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 3,180 views As GLP-1 therapies become a long-term cornerstone in diabetes care, monitoring patients on these treatments is gaining renewed attention
Since its discovery in ox bile in 1827, understanding of taurines role in increasing exercise performance is limited
However, there are emerging indications that employer sentiment may be shifting, as the survey also found that roughly 80% of human resources decision-makers expressed interest in expanding coverage for GLP-1s